Future directions with platelet growth factors

被引:18
作者
Kuter, DJ [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Hematol Oncol Unit, Boston, MA 02114 USA
关键词
D O I
10.1053/shem.2000.7390
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:41 / 49
页数:9
相关论文
共 47 条
[1]
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia [J].
Adams, JA ;
Yin, JAL ;
Brereton, ML ;
Briggs, M ;
Burgess, R ;
Hyde, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (01) :139-146
[3]
ASTER RH, 1967, J LAB CLIN MED, V70, P736
[4]
MECHANISMS OF THROMBOCYTOPENIA IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA - EVIDENCE OF BOTH IMPAIRED PLATELET PRODUCTION AND INCREASED PLATELET CLEARANCE [J].
BALLEM, PJ ;
SEGAL, GM ;
STRATTON, JR ;
GERNSHEIMER, T ;
ADAMSON, JW ;
SLICHTER, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01) :33-40
[5]
KINETIC-STUDIES OF THE MECHANISM OF THROMBOCYTOPENIA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BALLEM, PJ ;
BELZBERG, A ;
DEVINE, DV ;
LYSTER, D ;
SPRUSTON, B ;
CHAMBERS, H ;
DOUBROFF, P ;
MIKULASH, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (25) :1779-1784
[6]
Basser, 1997, BLOOD, V90, P2513
[7]
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer [J].
Basser, RL ;
Rasko, JEJ ;
Clarke, K ;
Cebon, J ;
Green, MD ;
Hussein, S ;
Alt, C ;
Menchaca, D ;
Tomita, D ;
Marty, J ;
Fox, RM ;
Begley, CG .
LANCET, 1996, 348 (9037) :1279-1281
[8]
Basser RL, 1997, BLOOD, V89, P3118
[9]
Coleman D, 1998, TOXICOL SCI, V45, P77
[10]
Crawford J, 1998, P AN M AM SOC CLIN, V17, p73a